Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology
Biotechnology · weight
1.89%
Industry change · 12M
+0.10 pp
Biotechnology · contribution
+0.104 pp
Company participation
100%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Jul 2026 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
AbbVie →
ABBV
United States$443.4bn0.774%+0.267 pp+0.070 pp+36.9%Yes
Vertex Pharmaceuticals →
VRTX
United States$121.1bn0.211%+0.064 pp-0.036 pp+4.4%Yes
Amgen →
AMGN
United States$207.9bn0.363%+0.110 pp+0.028 pp+34.4%Yes
Regeneron Pharmaceuticals →
REGN
United States$71.7bn0.125%+0.035 pp+0.017 pp+40.6%Yes
Moderna →
MRNA
United States$21.9bn0.038%+0.014 pp+0.014 pp+85.5%Yes
Biogen →
BIIB
United States$30.0bn0.052%+0.014 pp+0.013 pp+58.6%Yes
Gilead Sciences →
GILD
United States$161.7bn0.282%+0.062 pp-0.012 pp+19.0%Yes
Incyte →
INCY
United States$23.9bn0.042%+0.016 pp+0.011 pp+59.6%Yes

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.